SHAREHOLDER ALERT: Weiss Law Investigates Orthofix Medical Inc. – Orthofix Medical (NASDAQ:OFIX), SeaSpine Holdings (NASDAQ:SPNE) – Press Release
[ad_1]
NEW YORK, Oct. 14, 2022 /PRNewswire/ — Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Orthofix Medical Inc. (“Orthofix” or the “Company”) OFIX in connection with the proposed acquisition of the Company by SeaSpine Holdings Corporation (“SeaSpine”) SPNE. Under the terms of the merger agreement, the Company’s shareholders will receive 0.4163 shares of SeaSpine common stock for each Orthofix share owned, representing implied per-share merger consideration of approximately $2.44 based upon SeaSpine’ October 13, 2022 closing price of $5.86. Upon completion of the transaction, Orthofix shareholders will own approximately 56.5 percent of the combined company, and SeaSpine shareholders will own approximately 43.5 percent of the combined company.
If you own Orthofix shares and wish to discuss this investigation or have any questions concerning this notice or your rights or interests, visit our website:
https://www.weisslaw.co/news-and-cases/ofix
Or please contact:
Joshua Rubin, Esq.
Weiss Law
305 Broadway, 7th Floor
New York, NY 10007
(212) 682-3025
(888) 593-4771
stockinfo@weisslawllp.com
Weiss Law is investigating whether (i) Orthofix’s board of directors acted in the best interests of Company shareholders in agreeing to the proposed transaction, (ii) the per-share merger consideration adequately compensates Orthofix’s shareholders, and (iii) all information regarding the sales process and valuation of the transaction will be fully and fairly disclosed.
Weiss Law has litigated hundreds of stockholder class and derivative actions for violations of corporate and fiduciary duties. We have recovered over a billion dollars for defrauded clients and obtained important corporate governance relief in many of these cases. If you have information or would like legal advice concerning possible corporate wrongdoing (including insider trading, waste of corporate assets, accounting fraud, or materially misleading information), consumer fraud (including false advertising, defective products, or other deceptive business practices), or anti-trust violations, please email us at stockinfo@weisslawllp.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/shareholder-alert-weiss-law-investigates-orthofix-medical-inc-301649753.html
<style>
.adBox { text-align: center; }
</style>
SOURCE Weiss Law
[ad_2]
Source link
